Morgan Stanley Dr Reddys Laboratories LTD Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Morgan Stanley holds 2,030,028 shares of RDY stock, worth $153 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,030,028
Previous 876,889
131.5%
Holding current value
$153 Million
Previous $64.3 Million
140.47%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding RDY
# of Institutions
232Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$155 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$154 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$150 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$135 Million0.0% of portfolio
-
Aikya Investment Management LTD London, X01.39MShares$104 Million30.55% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.5B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...